155 related articles for article (PubMed ID: 987160)
1. Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
Land JM; Mowbray J; Clark JB
J Neurochem; 1976 Apr; 26(4):823-30. PubMed ID: 987160
[No Abstract] [Full Text] [Related]
2. [Phenylalanine and tyrosine in albino rat brain in the normal state and in experimental phenylketonuria].
Kaplanskiĭ SIa; Akopian ZhI
Ukr Biokhim Zh; 1967; 39(1):34-7. PubMed ID: 5628879
[No Abstract] [Full Text] [Related]
3. Inhibition, by 2-oxo acids that accumulate in maple-syrup-urine disease, of lactate, pyruvate, and 3-hydroxybutyrate transport across the blood-brain barrier.
Cremer JE; Teal HM; Cunningham VJ
J Neurochem; 1982 Sep; 39(3):674-7. PubMed ID: 7201506
[TBL] [Abstract][Full Text] [Related]
4. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
Lees GJ; Weiner N
J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
[No Abstract] [Full Text] [Related]
5. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and alpha-ketoisocaproate.
Halestrap AP; Brand MD; Denton RM
Biochim Biophys Acta; 1974 Oct; 367(1):102-8. PubMed ID: 4418160
[No Abstract] [Full Text] [Related]
6. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
Kindt E; Halvorsen S
Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
[TBL] [Abstract][Full Text] [Related]
7. Possible biochemical model for phenylketonuria.
Bowden JA; McArthur CL
Nature; 1972 Jan; 235(5335):230. PubMed ID: 4551128
[No Abstract] [Full Text] [Related]
8. Decreased essential amino acid requirements without catabolism in phenylketonuria and maple syrup urine disease.
Ruch T; Kerr D
Am J Clin Nutr; 1982 Feb; 35(2):217-28. PubMed ID: 7064884
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pyruvate and beta-hydroxybutyrate oxidation in rat brain mitochondria by phenylpyruvate and alpha-ketoisocaproate.
Land JM; Clark JB
FEBS Lett; 1974 Aug; 44(3):348-51. PubMed ID: 4413896
[No Abstract] [Full Text] [Related]
10. Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria.
Zielke HR; Zielke CL; Baab PJ; Collins RM
Neurochem Int; 2002 Apr; 40(4):347-54. PubMed ID: 11792465
[TBL] [Abstract][Full Text] [Related]
11. Impairment of hepatic pyruvate metabolism in phenylketonuria.
Sutnick M; Grover W; Patel M
Life Sci; 1974 Dec; 15(11):1945-53. PubMed ID: 4620999
[No Abstract] [Full Text] [Related]
12. Pyruvate metabolism by homogenates of human brain: effects of phenylpyruvate and implications for the etiology of the mental retardation in phenylketonuria.
Patel MS; Grover WD; Auerbach VH
J Neurochem; 1973 Feb; 20(2):289-96. PubMed ID: 4698280
[No Abstract] [Full Text] [Related]
13. Trace element disturbances in dietetically treated patients with phenylketonuria and maple syrup urine disease.
Lombeck I; Kasperek K; Feinendegen LE; Bremer HJ
Monogr Hum Genet; 1978; 9():114-7. PubMed ID: 732826
[No Abstract] [Full Text] [Related]
14. Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
Lysiak W; Stepiński J; Angielski S
Acta Biochim Pol; 1970; 17(2):131-41. PubMed ID: 5530500
[No Abstract] [Full Text] [Related]
15. The effect of phenylpyruvate on pyruvate metabolism in rat brain.
Patel MS
Biochem J; 1972 Jul; 128(3):677-84. PubMed ID: 4634834
[TBL] [Abstract][Full Text] [Related]
16. [Phenylketonuria].
Berger R; Broyer M
Presse Med (1893); 1968 Apr; 76(19):915-6. PubMed ID: 5689510
[No Abstract] [Full Text] [Related]
17. The effects of L-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex.
Glazer RI; Weber G
Brain Res; 1971 Oct; 33(2):439-50. PubMed ID: 5167448
[No Abstract] [Full Text] [Related]
18. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites.
Gibson GE; Blass JP
J Neurochem; 1976 Jun; 26(6):1073-8. PubMed ID: 945329
[No Abstract] [Full Text] [Related]
19. [Aminoacid metabolism disorders in infancy with special reference to phenylketonuria. II. Aminoacid metabolism and general physiopathology of aminoacidopathies].
Segni G
Minerva Nipiol; 1970; 20(4):83-110. PubMed ID: 4396023
[No Abstract] [Full Text] [Related]
20. A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria.
Langenbeck U; Behbehani A; Mench-Hoinowski A
J Inherit Metab Dis; 1992; 15(1):136-44. PubMed ID: 1583868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
